Taclonex
NDC Package 54868-5680-0
Package Information
Taclonex is this product contains 2 drugs (betamethasone and calcipotriene) and is used to treat psoriasis of the scalp. Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-5680 and is authorized under FDA application NDA021852.
Identification & Billing
- RxCUI: 388525 - calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment
- RxCUI: 388525 - betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment
- RxCUI: 388525 - betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment
- RxCUI: 388525 - betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment
- RxCUI: 388525 - betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-5680 - Taclonex
- 54868-5680-0 - 100 CARTON in 1 CASE / 1 TUBE in 1 CARTON / 60 g in 1 TUBE
- 54868-5680 - Taclonex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-5680-0 identifies a specific commercial package of 100 carton in 1 case / 1 tube in 1 carton / 60 g in 1 tube of Taclonex, labeled by Physicians Total Care, Inc.. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on October 20, 2010. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This product contains 2 drugs (betamethasone and calcipotriene) and is used to treat psoriasis of the scalp. Some brands of this medication are also used to treat psoriasis on the body. Betamethasone is a very strong corticosteroid drug that helps decrease the swelling, redness, and itching of the skin that occurs with this condition. Calcipotriene, which is also known as calcipotriol in other countries, is a form of vitamin D. It works by slowing down the growth of skin cells so that they do not build up into thickened, scaly skin patches. This medication should not be used if you have certain types of psoriasis (skin patches with pus-filled blisters, psoriasis with intense redness/shedding/oozing). Consult your doctor for more information. This product is not recommended for use in children because they may be at an increased risk for side effects. See also Side Effects and Precautions sections.
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868568000. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
